Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV001196440 | SCV001367048 | uncertain significance | Vanishing white matter disease | 2018-10-24 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PM2,PP3. |
Labcorp Genetics |
RCV001859184 | SCV002244827 | uncertain significance | not provided | 2021-08-20 | criteria provided, single submitter | clinical testing | This variant, c.144_146del, results in the deletion of 1 amino acid(s) of the EIF2B4 protein (p.Lys49del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs772427644, ExAC 0.01%). This variant has not been reported in the literature in individuals affected with EIF2B4-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |